ARWR Arrowhead Pharmaceuticals, Inc.

NASDAQ
$47.78

Arrowhead Pharmaceuticals, Inc. (ARWR) Earnings News

Earnings press releases, previews and reviews for Arrowhead Pharmaceuticals, Inc. (ARWR), newest first. Our most recent is review: Arrowhead's Deep Fourth-Quarter Miss Collides With an Accelerated SHTG Timeline and Inflecting REDEMPLO Demand.